As a substrate of DPP-4, inhibition of SDF-1α degradation preserves its effects with considerable benefit in acute myocardial infarction, cardiac recovery after ischemia-reperfusion, or stroke [95]. This evidence concerns the gene DPP4 and myocardial infarction.